AmerisourceBergen Welcomes New SVP…

CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Jan 25, 2022–

As part of AmerisourceBergen’s commitment to fostering a diverse and inclusive workplace, the global healthcare company today announced the appointment of Ann Anaya as the organization’s SVP and Chief Diversity Equity and Inclusion Officer.

In this position, Anaya will lead the Office of Diversity, Equity and Inclusion (DEI) and be responsible for driving AmerisourceBergen’s global DEI strategy to enable a more inclusive culture, foster more engaging environments and deliver more favorable customer and patient outcomes.

“Investing in our people and fostering a culture that is purpose-driven and inclusive is an integral part of AmerisourceBergen’s strategy. The appointment of Ann is a continuation of our commitment to supporting DEI initiatives and creating an environment where all of our team members can feel empowered, respected and included,” said Gina Clark, EVP, Chief Administration and Communications Officer at AmerisourceBergen. “Ann brings tremendous experience to this role and I am looking forward to her innovative approach that will drive meaningful and measurable change while further accelerating our diversity and inclusion journey.”

Prior to assuming her role at AmerisourceBergen, Anaya spent nearly nine years at 3M, with the past five years as their Chief Diversity Officer and Vice President of Global Inclusion. While in this role, Anaya received numerous awards and honors such as Hispanic Executive’s top 10 leaders of 2021 and Top 100 Chief Diversity Officers by the National Diversity Council. Anaya also spent more than 11 years serving as an Assistant United States Attorney for the District of Minnesota. She has a doctorate in law with distinction from the University of Minnesota Law School and holds a bachelor’s degree in political science from the University of Minnesota College of Liberal Arts.

About AmerisourceBergen

AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies, and providers, we create unparalleled access, efficiency, and reliability for human and animal health. Our 42,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #8 on the Fortune 500 with more than $200 billion in annual revenue. Learn more at https://amerisourcebergen.com/.

View source version on businesswire.com:https://www.businesswire.com/news/home/20220125005352/en/

CONTACT: Lauren Esposito, AmerisourceBergen

215-460-6981

LEsposito@amerisourcebergen.com

KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA

INDUSTRY KEYWORD: GENERAL HEALTH PHARMACEUTICAL HEALTH

SOURCE: AmerisourceBergen

Copyright Business Wire 2022.

PUB: 01/25/2022 09:30 AM/DISC: 01/25/2022 09:32 AM

http://www.businesswire.com/news/home/20220125005352/en

  • Positive Cases Among Kern Residents: 204,686

  • Deaths: 1,977

  • Recovered and Presumed Recovered Residents: 162,946

  • Percentage of all cases that are unvaccinated: 82.34

  • Percentage of all hospitalizations that are unvaccinated: 91.04

  • Source: Kern County Public Health Services Department

Updated: 1/25/21

More Coronavirus coverage

Source

Hippo Sighting Report

Help us out, we really appreciate it.

Help contribute to our research, and let us know if you have seen similar situations that we may have missed. Our team will review the details you provide and add to our main list once we verify the information.

stay informed

Subscribe and get the updated Hippo List.

Get notified when we release our updated lists by email.

Make a Donation

Thank you for subscribing!

We will send you an email to confirm your details.  Welcome aboard!

Thanks for sending us your report.

We will review your information, and publish in on our list once we validate the details.